--- title: "Life Science Office REITs Industry" description: "Life science office REITs own laboratory and office space leased to biotechnology, pharmaceutical and research tenants." canonical: https://www.getswoopr.com/stocks/industries/real-estate/life-science-office-reits/ source: "Swoopr Investment: https://www.getswoopr.com" --- # Life Science Office REITs Industry ## Direct Answer Life science office REITs own laboratory and office space leased to biotechnology, pharmaceutical and research tenants, usually in a few clusters such as Boston, San Francisco and San Diego. Rents are set by tenant funding and the supply of new lab space. ## Industry Overview Life Science Office REITs sits within the real estate sector. The first numbers to compare across companies here are occupancy and leasing spreads, same-property net operating income growth and tenant credit quality and funding. The outside forces that move them are listed under Primary Macro Drivers. ## Key Industry Metrics - **Occupancy and leasing spreads**: The share of lab and office space leased, and the rent change on new leases against the prior rent. Falling occupancy with negative spreads signals oversupply or weaker tenant funding. - **Same-property net operating income growth**: The change in rent less property costs on buildings owned in both periods. It strips out acquisitions and development, so it shows how existing lab space is performing. - **Tenant credit quality and funding**: How financially secure the research tenants are, including their cash runway and capital raising. Funding drives rent payments here, so weak credit is a leading warning on collections. - **Development pipeline and yield on cost**: Space under construction and the expected annual income divided by total project cost. A yield well above current market cap rates shows value creation, but delays and cost overruns erode it. - **Funds from operations per share**: Net income with property depreciation added back and gains on sales removed, divided by shares. It is the standard REIT earnings measure, read against dividends and share-count growth. ## Primary Macro Drivers - **Biotechnology venture and public funding**: When biotech companies raise money they lease and expand lab space, so funding volume shows up in occupancy and leasing spreads; tight funding does the reverse. - **Construction of competing lab space**: Each new lab building adds supply in the same clusters, so heavy construction pressures occupancy and rent growth, visible in leasing spreads and same-property NOI. - **Interest rates and cap rates**: Higher rates raise financing cost and lift the yields buyers require, which pushes property values down and raises the hurdle for development yield on cost. - **Concentration in a few research clusters**: Most space sits in a few clusters, so local supply or funding shifts hit the whole portfolio at once, visible in occupancy and NOI by market. ## Major Risks - **Oversupply of lab space**: New supply and weaker demand together leave buildings empty, so watch occupancy, leasing spreads and the volume of available lab space in the main clusters. - **Tenant defaults when funding tightens**: Many tenants are pre-revenue and depend on funding rounds, so look at tenant credit disclosures, rent collection and any move to sublease space. - **Development cost overruns**: Lab buildouts are specialized and expensive, so rising materials and labor costs cut the yield on cost, shown in development pipeline updates and delivery dates. - **Refinancing at higher rates**: Debt that comes due must be refinanced at current rates, so check the maturity schedule and the interest expense trend against funds from operations per share. ## Industry Characteristics | Characteristic | Profile | | --- | --- | | Cyclicality | Mixed | | Capital Intensity | High | | Regulatory Intensity | Medium | | Industry Maturity | Growth | | Geographic Importance | U.S. | ## Companies Associated with Life Science Office REITs The SEC's Standard Industrial Classification has no code that describes life science office reits as a group, so there is no complete list of its filers. The companies below come from Swoopr's SEC dataset and have operations in or next to the industry. Each is classified by the SEC under its own main business. | Company | SEC classification | Revenue | Growth | Net margin | Year | | --- | --- | --- | --- | --- | --- | | [Alexandria Real Estate Equities, Inc.](https://www.getswoopr.com/stocks/companies/alexandria-real-estate-equities/) | Real Estate Investment Trusts | $3.0 billion | -2.9% | -47.2% | FY 2025 | | [Healthpeak Properties, Inc.](https://www.getswoopr.com/stocks/companies/healthpeak-properties/) | Real Estate Investment Trusts | $2.8 billion | 4.5% | 2.5% | FY 2025 | Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. Listing here describes a business relationship to the industry, not a recommendation. To find more companies, use the [company directory](https://www.getswoopr.com/stocks/companies/) and the [real estate hub](https://www.getswoopr.com/stocks/industries/real-estate/). ## Where to Go Next The Life Science Office REITs guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company. ### More in Real Estate - [Real Estate sector overview](https://www.getswoopr.com/stocks/industries/real-estate/) - [Lodging & Resort REITs](https://www.getswoopr.com/stocks/industries/real-estate/lodging-and-resort-reits/) - [Infrastructure REITs](https://www.getswoopr.com/stocks/industries/real-estate/infrastructure-reits/) - [Logistics REITs](https://www.getswoopr.com/stocks/industries/real-estate/logistics-reits/) - [Industrial REITs](https://www.getswoopr.com/stocks/industries/real-estate/industrial-reits/) - [Mall REITs](https://www.getswoopr.com/stocks/industries/real-estate/mall-reits/) - [Health Care REITs](https://www.getswoopr.com/stocks/industries/real-estate/health-care-reits/) - [Manufactured Housing REITs](https://www.getswoopr.com/stocks/industries/real-estate/manufactured-housing-reits/) - [Gaming REITs](https://www.getswoopr.com/stocks/industries/real-estate/gaming-reits/) ### Put it to work - [How to analyze a stock](https://www.getswoopr.com/stocks/how-to-analyze-a-stock/) - [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/) - [Company research](https://www.getswoopr.com/stocks/companies/) - [All industries](https://www.getswoopr.com/stocks/industries/) ## Frequently Asked Questions What are the main KPIs for the Life Science Office REITs industry? Key performance indicators for the Life Science Office REITs industry include: Occupancy and leasing spreads, Same-property net operating income growth, Tenant credit quality and funding, Development pipeline and yield on cost, Funds from operations per share. Which matter most depends on the company's model, so compare them across several companies rather than relying on one. How cyclical is the Life Science Office REITs industry? The Life Science Office REITs industry exhibits mixed cyclicality characteristics. Some segments move with the broader economy while others maintain more stable demand, making stock selection within the group particularly important. What are the biggest risks in the Life Science Office REITs industry? The primary risks for Life Science Office REITs companies include: Oversupply of lab space, Tenant defaults when funding tightens, Development cost overruns, Refinancing at higher rates. Investors should assess each company's exposure to these factors and its track record of navigating them. **[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)** Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).